Research Shelf
For Research Use Only.
Online Inquiry
-
Pharmacokinetics Studies
- In Vitro ADME
- Anti-Drug Antibody
- In Vivo PK Studies
-
Pharmacodynamics Studies
- Tumor Models & Pharmacodynamics
- Neurological Disorder Models & Pharmacodynamics
- Alzheimer’s Disease Models
- Parkinson’s Disease Models
- Amyotrophic Lateral Sclerosis Model
- Multiple Sclerosis Models
- Huntington’s Disease Model
- Spinal Cord Injury Model
- Stroke & Brain Ischemia Models
- Traumatic Brain Injury Models
- Pain Models
- Migraine Models
- Autism Spectrum Disorder Model
- Schizophrenia Models
- LPS induced Neuroinflammation Model
- DMD Model
- Rett Syndrome Model
- SMA Model
- Epilepsy Models
- Depression Models
- Anxiety Models
- Drug Abuse Liability Models
- Behavioral Tests for Motor Function
- Behavioral Tests for Cognition
- Social Behavior Tests
- Sleep Disorder Models
- Primate Neurological Disease Models
- SCI Model
- Cerebral Infarction Model
- Cerebral Stroke Model
- Primate PNI Model
- Primate VaD Model
- Primate Depression & Anxiety Model
- Inflammation & Immunological Disease Models & Pharmacodynamics
- Carrageenan Air Pouch Model
- Carrageenan induced Paw Edema Model
- IMQ induced Psoriasis Model
- Chemical induced Contact Hypersensitivity Model
- PCA Model
- DTH Model
- AIA Model
- CIA Model
- CAIA Model
- CLP induced Sepsis Model
- LPS induced Sepsis Model
- Spontaneous SLE Model
- Induced Model of SLE
- 2-HIT Model of Sepsis
- Immune Disease Models
- Metabolic/Liver Disease Models & Pharmacodynamics
- Obesity Models
- Diabetes Models
- Diabetes Complication Models
- Hyperlipidemia Models
- NASH Models
- DIO NASH Model
- HFD induced NASH Model
- MCD Diet induced NASH Model
- CDAA Diet induced NASH Model
- HFHC Diet induced NASH Model
- High-Fat & High-Cholesterol Diet induced NASH Model
- High-Fat & High-Cholesterol Diet & Fructose induced NASH Model
- High-Fat & High-Fructose induced NASH Model
- DEN & High-Fat & High-Cholesterol Diet induced NASH Model
- High-Fat & CCL₄ induced NASH Model
- STZ & High-Fat induced NASH Model
- MC4R KO Mouse Model
- LDLR KO Mouse Model
- Acute Liver Injury Models
- CCL₄ induced Acute Liver Injury Model
- Con A induced Acute Liver Injury Model
- Poly I:C induced Acute Liver Injury Model
- APAP induced Acute Liver Injury Model
- Alcohol induced Acute Liver Injury Model
- Ischemia-Reperfusion induced Liver Injury Model
- ANIT induced Acute Liver Injury Model
- DDC induced Acute Liver Injury Model
- Liver Fibrosis/Cirrhosis Models
- Pancreatic Fibrosis Model
- Gout Models
- Sarcopenia Models
- Hepatitis B Models
- HBV Infection & Liver Fibrosis Combination Models
- Metabolic Disorder Models
- Liver Disease Models
- Urological System Disease Models & Pharmacodynamics
- Autoimmune Nephropathy Models
- Acute Kidney Injury Models
- Gentamicin induced Acute Renal Failure Model
- Cisplatin induced Acute Renal Failure Model
- Glycerol induced Acute Renal Failure Model
- Contrast Agent induced Acute Kidney Injury Model
- Folic Acid induced Acute Kidney Injury Model
- LPS induced Acute Kidney Injury Model
- CLP induced Acute Kidney Injury Model
- LPA induced Acute Kidney Injury Model
- GHRH induced Acute Kidney Injury Model
- Anti-TSHR Antibody induced Acute Kidney Injury Model
- Aristolochic Acid A induced Acute Kidney Injury Model
- Renal IR Model
- Chronic Kidney Disease Models
- Metabolic Nephropathy Models
- Hyperuricemia Models
- Kidney Transplantation Models
- Cystitis Models
- Urogenital Disease Model
- CRF Model
- ARF Model
- RH Model
- Primate DN Model
- BPH Model
- OAB Model
- Digestive System Disease Models & Pharmacodynamics
- Cardiovascular Disease Models & Pharmacodynamics
- Myocardial Infarction Models
- Heart Failure Models
- AMI induced Left HF Model
- PA Constriction induced Right HF Model
- Ascending Aortic Arch Constriction induced Post-Pressure Overload Heart Failure Model
- Abdominal Aortic Stenosis induced Left HF Model
- DOCA & Salt induced Left HF Model
- Salt induced Left HF Model
- Adriamycin induced Left HF Model
- Isoproterenol induced Chronic Heart Failure Model
- AngII induced Chronic Heart Failure Model
- ACF induced Anterior Pressure Overload Heart Failure Model
- HFD induced Heart Failure Model
- HFHC Diet induced Heart Failure Model
- 5/6 Nephrectomy induced Heart Failure Model
- Pulmonary Hypertension induced Right Heart Failure Model
- Renal Artery Constriction induced Hypertensive Heart Failure Model
- Doxorubicin induced Cardiomyopathy Model
- Primate HF Model
- Atherosclerosis Models
- Hypertension Models
- SHR Model
- Salt induced Hypertentison Model
- 5/6 Nephrectomy induced Hypertension Model
- Renal Artery Stenosis induced Hypertension Model
- Abdominal Aorta Constriction induced Hypertension Model
- DOCA-Salt induced Hypertension Model
- L-NAME induced Hypertension Model
- Monocrotaline induced Pulmonary Hypertension Model
- Hypoxia induced Pulmonary Hypertension Model
- Angiotensin-2 Infusion induced Hypertension Model
- hRN/hANG Transgentic Mouse Hypertension Model
- Primate Hypertension Model
- Thrombosis Models
- Transient Blood Flow Occlusion induced Inferior Vena Cava Thrombosis Model
- Thrombin induced Inferior Vena Cava Thrombosis Model
- Arteriovenous Fistula Thrombosis Model
- Fe₂O₃ induced Arterial Thrombosis Model
- Foreign Matter induced Arterial Thrombosis Model
- Ferric Chloride induced Thrombosis Model
- Primate Thrombosis Model
- Peripheral Vascular Disease Models
- Stroke Models
- Atrial Fibrillation Models
- Ventricular Tachycardia Models
- Disseminated Intravascular Coagulation Models
- Pericarditis Models
- Myocarditis Models
- Diabetic Complication Model
- Primate Cardiovascular Disease Model
- Primate Arrhythmia Model
- Primate Myocardial Fibrosis Model
- Primate PAD Model
- Primate Carotid Arterial Stenosis Model
- Ocular Disease Models & Pharmacodynamics
- Musculoskeletal Disease Models & Pharmacodynamics
- Respiratory Disease Models & Pharmacodynamics
- Infectious Disease Animal Models & Pharmacodynamics
- In Vitro Pharmacodynamic
-
Gene Editing
- Model Creation Technologies
- Knockout Models
- Knockin Models
- Knockdown Model
- Humanized Mouse Models
- Humanized PBL SCID Mouse Model
- Humanized SRC SCID Mouse Model
- Humanized Immune Checkpoint Mouse Models
- hPD-1/hCD47 Dual Humanized Mouse Model
- hPD-1/hGITR Dual Humanized Mouse Model
- hPD-L1/hSIRPα/hCD47 Triple Humanized Mouse Model
- hPD-1/hPD-L1/hIDO1 Triple Humanized Mouse Model
- hPD-1/hPD-L1/hOX40 Triple Humanized Mouse Model
- hPD-1/hPD-L1/hPD-L2 Triple Humanized Mouse Model
- hPD-1/hPD-L1/hCTLA-4 Triple Humanized Mouse Model
- hPD-1/hTIGIT/hTIM3 Triple Humanized Mouse Model
- hPD-1/hPD-L1/hTIGIT Triple Humanized Mouse Model
- hPD-1/hPD-L1/hLAG3 Triple Humanized Mouse Model
- hPD-1/hPD-L1/h4-1BB Triple Humanized Mouse Model
- hSIRPα/hCD47/hPD-1 Triple Humanized Mouse Model
- hCD3EDG Triple Humanized Mouse Model
- hPD-1/hPD-L1/hSIRPα/hCD47 Quadruple Humanized Mouse Model
-
Toxicology Studies
- In Vitro Toxicity Tests
- In Vitro Safety Pharmacology Studies
- Toxicity & Safety Evaluation
- General Toxicity Studies
- Local Toxicity Studies
- Developmental & Reproductive Toxicology
- Immunotoxicity
- Carcinogenicity
- Genotoxicity
- Neurotoxicity
- Skin Toxicology
- Cardiovascular Toxicity
- Respiratory Toxicity
- Gastrointestinal Toxicity
- Liver Toxicity
- Kidney Toxicity
- Phototoxicity
- Ocular Toxicity
- Musculoskeletal Toxicity
- Drug Abuse Liability
- Ecotoxicity
- Inhalation Toxicity
- Infusion Toxicology
- Juvenile Toxicity
- Safety Pharmacology
- Resources
- Platforms
- Company